PostEra is an AI-first biotech. We're using Proton, our AI platform for medicinal chemistry, to advance an internal pipeline of small molecule programs in Women's Health and Fertility. We expect to launch two Phase I trials in 2026. We've also partnered on over $1Bn of AI deals across 4 partnerships with Pfizer and Amgen.